Idiopathic Pulmonary Fibrosis and Myasthenia Gravis: An Unusual Association
Published: April 1, 2016 | DOI: https://doi.org/10.7860/JCDR/2016/.7596
Bharti Chogtu, Daliparty Vasudev Malik, Rahul Magazine
1. Associate Professor, Department of Pharmacology, Kasturba Medical College,Manipal University, Manipal, Karnataka, India.
2. Postgraduate Student, Department of Pulmonary Medicine, Kasturba Medical College, Manipal University, Manipal, Karnataka, India.
3. Professor, Department of Pulmonary Medicine, Kasturba Medical College, Manipal University, Manipal, Karnataka, India.
Correspondence
Dr. Rahul Magazine,
Professor, Pulmonary Medicine, Kasturba Medical College,Manipal University,
Manipal-576104, Karnataka, India.
E-mail: rahulmagazine@gmail.com
Idiopathic Pulmonary Fibrosis (IPF) is a chronic fibrosing lung condition with high morbidity and mortality, accounting for about 25% of the cases of interstitial lung diseases. It usually has a progressive course resulting in death due to respiratory failure. Myasthenia Gravis (MG) is an autoimmune neuromuscular disease, caused by antibody mediated activity against acetylcholine receptor at the neuromuscular junction. It is characterized by fluctuating muscle weakness and fatigue. Extensive literature search did not reveal any case report of an association between these two conditions. Here we present a case of a patient with IPF who also developed MG. The diagnosis of IPF was based on High Resolution Computed Tomography (HRCT) of the lung and that of MG was based on clinical criteria and electrophysiological testing. The case was successfully managed.
[
FULL TEXT ] | [ PDF]